SARS-CoV-2 Vaccine Breakthrough by Omicron and Delta Variants, New York, USA
Article
[키워드] 2019 novel coronavirus disease
acute respiratory syndrome
age
Analysis
association
Case-control
conditional logistic regression
Control
coronavirus
coronavirus disease
COVID-19
dataset
Delta
genomic sequence
greater
Host
Infection
information
less
Lineage
Logistic
New
New York
not significant
Novel coronavirus
offered
omicron
Patient
respiratory infections
SARS-CoV-2
SARS-CoV-2 variant
severe acute respiratory syndrome coronavirus 2
significantly
United States
USA
vaccination
Vaccine
Vaccine breakthrough
vaccine breakthrough infections
variant
variants
virus
viruses
zoonoses
zoonoses.
[DOI] 10.3201/eid2810.221058 PMC 바로가기
[DOI] 10.3201/eid2810.221058 PMC 바로가기